Schmoch Thomas, Bernhard Michael, Becker-Pennrich Andrea, Hinske Ludwig Christian, Briegel Josef, Möhnle Patrick, Brenner Thorsten, Weigand Markus A
Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.
Anaesthesist. 2022 Feb;71(2):104-109. doi: 10.1007/s00101-021-01012-8. Epub 2021 Aug 5.
The 11th revision of the International Classification of Diseases (ICD-11) will come into effect in January 2022. Among other things, The Third International Consensus Definitions for Sepsis and Septic Shock (SEPSIS‑3 definition) will be implemented in it. This defines sepsis as a "life-threatening organ dysfunction caused by a dysregulated host response to infection". The aim of the present secondary analysis of a survey on the topic of "sepsis-induced coagulopathy" was to evaluate whether the SEPSIS‑3 definition, 4 years after its international introduction, has arrived in everyday clinical practice of intensive care units (ICU) run by anesthesiologists in Germany and thus the requirements for its use of the ICD-11 are given.
Between October 2019 and May 2020, we carried out a nationwide survey among German medical directors of ICUs. In a separate block of questions we asked about the definition of sepsis used in daily practice. In addition, we asked whether the quick-sequential (sepsis-related) organ failure assessment (qSOFA) score is used in screening for sepsis in the hospital to which to the participating ICU belongs.
A total of 50 medical directors from anesthesiological ICUs took part in the survey. In total, the ICUs evaluated stated that they had around 14% of the high-care beds registered in Germany. The SEPSIS‑3 definition is integrated into everyday clinical practice at 78.9% of the university hospitals and 84.0% of the participating teaching hospitals. In contrast, the qSOFA screening test is only used by 26.3% of the participating university hospitals, but at least 52% of the teaching hospitals and 80% of the other hospitals.
The data show that both SEPSIS‑3 and qSOFA have become part of everyday clinical practice in German hospitals. The cautious use of qSOFA at university hospitals with simultaneous broad acceptance of the SEPSIS‑3 definition can be interpreted as an indication that the search for a suitable screening test for sepsis has not yet been completed.
《国际疾病分类》(ICD - 11)第11版将于2022年1月生效。其中将实施《脓毒症和脓毒性休克第三次国际共识定义》(脓毒症 - 3定义)。该定义将脓毒症定义为“宿主对感染的反应失调引起的危及生命的器官功能障碍”。本次对“脓毒症诱导的凝血病”主题调查的二次分析旨在评估脓毒症 - 3定义在国际引入4年后,是否已进入德国麻醉医生管理的重症监护病房(ICU)的日常临床实践,从而确定其在ICD - 11中的使用要求。
2019年10月至2020年5月期间,我们对德国ICU的医疗主任进行了一项全国性调查。在单独的一组问题中,我们询问了日常实践中使用的脓毒症定义。此外,我们询问了参与调查的ICU所属医院在脓毒症筛查中是否使用快速序贯(脓毒症相关)器官功能衰竭评估(qSOFA)评分。
共有50位麻醉ICU的医疗主任参与了调查。总体而言,参与评估的ICU表示,他们拥有德国登记的约14%的重症监护床位。脓毒症 - 3定义在78.9%的大学医院和84.0%的参与调查的教学医院中已融入日常临床实践。相比之下,参与调查的大学医院中只有26.3%使用qSOFA筛查测试,但至少52%的教学医院和80%的其他医院使用。
数据表明,脓毒症 - 3定义和qSOFA都已成为德国医院日常临床实践的一部分。大学医院对qSOFA的谨慎使用以及对脓毒症 - 3定义的广泛接受,可以解释为对脓毒症合适筛查测试的探索尚未完成。